Feedback / Questions
ondansetron ultra-low dose (AD04) - Adial
alhydrogel injectable (AD04) - ADvantage Therap
http://clinicaltrials.gov/ct2/show/NCT07107074
Aug 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next